Novartis Foundation

Novartis Joins Global Initiative to Fight the Rise of Noncommunicable Diseases

Novartis joins more than 20 leading biopharmaceutical companies to launch “Access Accelerated”, a global initiative to further advance access to prevention and care for noncommunicable diseases in low and lower-middle income countries
Press Release

January 18, 2016 /3BL Media/ - On January 18, 2017 at the World Economic Forum in Davos, Switzerland, Novartis joins more than 20 leading biopharmaceutical companies to launch “Access Accelerated”, a global initiative to further advance access to prevention and care for noncommunicable diseases (NCDs) in low and lower-middle income countries (LICs and LMICs).

Novartis Dialogue Explores Response to Chronic Illness in Poor Countries

Health experts from around the world met on November 29 to discuss ways to tackle an emerging crisis.
Press Release

December 14, 2016 /3BL Media/ - Chronic conditions such as heart disease and cancer are a growing threat in the world’s poorest countries and public health experts from around the world met on November 29 to explore ways of tackling this silent epidemic. Chronic conditions such as heart disease and cancer are a growing threat in the world’s poorest countries and public health experts from around the world met on November 29 to explore ways of tackling this silent epidemic.

Novartis Access Shares One-year Learnings and Announces Memorandum of Understanding with Rwanda

Summary: 
  • Rwanda becomes third country to launch Novartis Access portfolio against chronic diseases with first deliveries planned in early 2017
  • Since September 2015, Novartis Access has delivered more than 100,000 monthly treatments to Kenya, Ethiopia and Lebanon*
  • First-year learnings underline broader systemic issues in roll-out countries
Press Release
  • Rwanda becomes third country to launch Novartis Access portfolio against chronic diseases with first deliveries planned in early 2017
  • Since September 2015, Novartis Access has delivered more than 100,000 monthly treatments to Kenya, Ethiopia and Lebanon*
  • First-year learnings underline broader systemic issues in roll-out countries

Join the Webcast: Novartis Dialogue to Explore Solutions to the Rise of Chronic Diseases in the Developing World

The event “Improving care for chronic patients in lower-income countries: the patient journey,” will take place November 29, 2016.
Press Release

November 24, 2016 /3BL Media/ - The event “Improving care for chronic patients in lower-income countries: the patient journey,” will take place November 29, 2016.

Novartis Access and the Novartis Foundation will be discussing chronic diseases with experts from academia and non-profit organizations speaking and attending.

Novartis Improves Ranking in 2016 Access to Medicine Index

Summary: 
  • Novartis ranks third in 2016 ranking
  • Company tops the industry in access-to-medicine management and capacity building

  • Novartis integrated access strategy addressing all income segments stands out as best practice

Press Release
  • Novartis ranks third in 2016 ranking
  • Company tops the industry in access-to-medicine management and capacity building

  • Novartis integrated access strategy addressing all income segments stands out as best practice

Novartis Foundation Showcases Progress In Leprosy Elimination Programs

19th International Leprosy Congress
Summary: 
  • Emerging evidence from first 18 months of LPEP program demonstrates operational feasibility integrating single-dose rifampicin into routine control programs in 6 countries

  • Retrospective contact tracing of former leprosy patients in Cambodia initiates phase 2 to accelerate diagnosis

  • Accuracy of first mobile phone-facilitated leprosy detection system to help identify patients in remote areas of the Philippines leads to recommendation for field use

  • Criteria for development of a molecular diagnostic test for leprosy determined

Press Release
  • Emerging evidence from first 18 months of LPEP program demonstrates operational feasibility integrating single-dose rifampicin into routine control programs in 6 countries

  • Retrospective contact tracing of former leprosy patients in Cambodia initiates phase 2 to accelerate diagnosis

  • Accuracy of first mobile phone-facilitated leprosy detection system to help identify patients in remote areas of the Philippines leads to recommendation for field use

  • Criteria for development of a molecular diagnostic test for leprosy determined

The High Stakes of Hypertension

Ann Aerts, Head of Novartis Foundation
Blog

BASEL – Most of us know about hypertension – at least we think we do. We understand that abnormally high blood pressure puts us at greater risk of heart attacks and stroke. And we also know that it is linked to diet and lifestyle, and can be treated with the right medication. But many would say that hypertension is primarily a “rich-country” problem, implying that most affected people have access to the right knowledge and treatment. That is not the case at all.

Novartis Foundation Convenes Experts to Examine the Promise and Practicality of Digital Technology to Improve Health in LMICs

Event will examine digital health as an enabler to expand patient reach, make services more affordable and empower patients to manage their own health
Summary: 
  • Experts at Ghana-based event will build a consensus on the necessary elements for digital health programs to reach scale and impact in Africa  
     
  • Co-hosted with the Ministry of Health Ghana and the Ghana Health Service, the program will highlight the importance of local ownership of digital health solutions 
Press Release
  • Experts at Ghana-based event will build a consensus on the necessary elements for digital health programs to reach scale and impact in Africa  
     
  • Co-hosted with the Ministry of Health Ghana and the Ghana Health Service, the program will highlight the importance of local ownership of digital health solutions 

Novartis Foundation and Partners Launch Innovative Hypertension Program in Vietnam

Nearly one quarter of the adult population in Vietnam has hypertension, but only 11% of these hypertensive patients have it under control
Summary: 
  • Ho Chi Minh City Communities for Healthy Hearts Program is the second innovative healthcare model for hypertension pioneered by the Novartis Foundation 

  • Screening and treatment shifts to the community via social entrepreneurs, while digital health technology empowers patients and health workers

  • Nearly one quarter of the adult population in Vietnam has hypertension, but only 11% of these hypertensive patients have it under control

  • Program partners include Ho Chi Minh City’s Provincial Health Department, PATH, the Hanoi School of Public Health and Lotus Impact 

Press Release
  • Ho Chi Minh City Communities for Healthy Hearts Program is the second innovative healthcare model for hypertension pioneered by the Novartis Foundation 

  • Screening and treatment shifts to the community via social entrepreneurs, while digital health technology empowers patients and health workers

  • Nearly one quarter of the adult population in Vietnam has hypertension, but only 11% of these hypertensive patients have it under control

  • Program partners include Ho Chi Minh City’s Provincial Health Department, PATH, the Hanoi School of Public Health and Lotus Impact 

The Novartis Foundation and the London School of Hygiene & Tropical Medicine Join Forces to Put Hypertension Care and Management on the Global Health Agenda

Press Release
  • Global Health and hypertension community gather to highlight innovative delivery models for hypertension management in low- and middle-income countries
  • Experts at London-based dialogue event will also focus on potential enablers to scale healthcare delivery models and critical need for evidence generation
  • Deaths from hypertension are estimated at 9.4 million people annually globally, which is equivalent to all infectious diseases combined

Pages

Subscribe to Novartis Foundation